primary antibodies against nf e2 (Proteintech)
Proteintech is a verified supplier 
93
Structured Review
Proteintech
primary antibodies against nf e2
Primary Antibodies Against Nf E2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 32 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+nf+e2/NFE2+Antibody/pm40571222-126-35-39
Average 93 stars, based on 32 article reviews
Primary Antibodies Against Nf E2, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 32 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/primary+antibodies+against+nf+e2/NFE2+Antibody/pm40571222-126-35-39
Average 93 stars, based on 32 article reviews
primary antibodies against nf e2 - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Binding Assay:Article Title: Ferulic acid promotes thrombopoiesis via TLR4/JAK2/STAT3 signaling: A novel therapeutic strategy for thrombocytopenia. Article Snippet: Thrombocytopenia, a common hematological disorder, is associated with increased mortality in various diseases.. However, the existing clinical treatments are often accompanied by various adverse effects and may even disrupt platelet homeostasis, highlighting the urgent need to develop novel therapeutic agents.. Here, we developed a drug screening model based on virtual screening utilizing known monomeric components of Sanguisorba officinalis L. (SOL) and identified ferulic acid (FA) as a promising candidate for thrombocytopenia intervention. Incubation:Article Title: Ferulic acid promotes thrombopoiesis via TLR4/JAK2/STAT3 signaling: A novel therapeutic strategy for thrombocytopenia. Article Snippet: Thrombocytopenia, a common hematological disorder, is associated with increased mortality in various diseases.. However, the existing clinical treatments are often accompanied by various adverse effects and may even disrupt platelet homeostasis, highlighting the urgent need to develop novel therapeutic agents.. Here, we developed a drug screening model based on virtual screening utilizing known monomeric components of Sanguisorba officinalis L. (SOL) and identified ferulic acid (FA) as a promising candidate for thrombocytopenia intervention. Article Title: Targeting TLR2/Rac1/cdc42/JNK Pathway to Reveal That Ruxolitinib Promotes Thrombocytopoiesis Article Snippet: .. After that, the cells were washed twice with PBS and blocked with 5% BSA for 60 min. Then, |